About Sheila Gujrathi, M.D.
Sheila Gujrathi, M.D. is a chief executive officer and director at Prana Therapies.
Experience
This experience comes from Sheila Gujrathi, M.D.'s profile and from SEC filings. For roles taken from filings, the years are when the filings name Sheila Gujrathi, M.D. in the role, so the role may have started earlier or lasted longer.
BI
BlossomHill Therapeutics, Inc. Current
Lead Independent Director
2026 – Present
AA
American Institute for Medical and Biological Engineering (AIMBE) Current
Fellow
2025 – Present
VT
Vidya Therapeutics Current
Founder and Executive Chair
2024 – Present
GE
Generian Current
Executive Chair
2023 – Present
LB
Lila Bio Current
Co-Founder and Executive Chair
2022 – Present
Prana Therapies, Inc. Current
Founder and CEO (2021 – Present)
Director
2021 – Present · Encinitas, CA
Develops antibody medicines for people with respiratory and skin diseases.
BS
Biotech CEO Sisterhood Current
Co-Founder
2021 – Present
JT
Janux Therapeutics
Director Board Of Directors
2021 – 2026
VB
Ventyx Biosciences
Executive Chair of the Board of Directors
2021 – 2026
AI
ADARx Pharmaceuticals Inc.
Chair of the Board of Directors
2020 – 2025
GT
Gale Therapeutics
Co-Founder and Acting Chief Executive Officer
2023 – 2024
PS
Pacific Ridge School
Member Board of Trustees
2022 – 2024
IB
IMMPACT BIO
Chair Of The Board Of Directors
2021 – 2024
OR
OrbiMed
Venture Advisor
2021 – 2023
BO
Biotechnology Innovation Organization
Board Member
2019 – 2021
TT
Turning Point Therapeutics
Chair of the Board of Directors
2017 – 2021
GB
Gossamer Bio
Co-Founder and Chief Executive Officer
2016 – 2020
FI
Five Prime Therapeutics, Inc.
Director Board Of Directors
2015 – 2019
AM
Ambrx
Director Board Of Directors
2014 – 2015
RI
Receptos, Inc.
Chief Medical Officer
2011 – 2015
Key Colleagues at Startups
The people Sheila Gujrathi, M.D. works with at each company, as listed on that company's latest Form D.
Prana Therapies, Inc. · Form D, Aug 10, 2026
BA
Ben Auspitz
Director

Hector Ortega
Chief Medical Officer

Ryan Sullivan
Chief Scientific Officer
AB
Alexis Borisy
Director